logo
  • 热门搜索词:
热门搜索词:专利数据招投标二手房交易数据专利引用数据世界版上市公司专利上市公司招聘股吧文本数据工商统计数据法拍房新闻报纸数据
COVID-19 Pandemic Data

China Nucleic Acid Testing Facilities and Sampling Sites DataNEW

China Nucleic Acid Testing Facilities Information Table
China Nucleic Acid Sampling Sites Information Table

Nucleic Acid Testing Facilities Business Registration DataNEW

Nucleic Acid Testing Facilities Basic Business Data
Nucleic Acid Testing Facilities Registration Capital Data
Nucleic Acid Testing Facilities Actual Controller Data
Nucleic Acid Testing Facilities Shareholder Basic Data
Nucleic Acid Testing Facilities Shareholder External Investment Data
Nucleic Acid Testing Facilities External Investment Data
Nucleic Acid Testing Facilities Controlled Enterprises Data
Nucleic Acid Testing Facilities Business Change Data

Nationwide Community COVID-19 Confirmed Cases Data

COVID-19 Prevention Patent Information DataOPEN

China Prevention Patent Information Table
World Prevention Patent Information Table
China Prevention Patent Legal Status Table

COVID-19 Prevention Enterprise Donation DataOPEN

COVID-19 Prevention Standard Information DataOPEN

Medical Protective Products Full Table
Port Health Quarantine Table
Medical Infrastructure Full Table

Introduction to Industrial and Commercial Registration Data of Nucleic Acid Testing Institutions

   Since the outbreak of COVID-19, nucleic acid testing has played a proactive role in early detection of positive cases based on practical experience from nationwide pandemic containment efforts, and has been vigorously promoted as a fundamental measure for regular epidemic prevention and control. Currently, specialized nucleic acid testing institutions have been established across China. According to regulations from the National Health Commission, there are three main types of healthcare institutions providing nucleic acid testing services in China: 1) medical institutions such as hospitals and maternal and child health centers; 2) disease control agencies, including centers at national, provincial, municipal, and county levels; and 3) medical testing laboratories, categorized as healthcare institutions and commonly referred to as "third-party testing institutions".

   By the end of 2022, health administrative departments in Lanzhou, Beijing, Hefei, Shijiazhuang, Xuchang, Inner Mongolia, and other regions discovered serious illegal activities involving falsified test reports by certain testing institutions, with particular societal scrutiny directed at third-party testing companies.

   Against this backdrop, CnOpenData has collected comprehensive industrial and commercial basic information, shareholder details, external investment records of shareholders, and registration change histories for all nucleic acid testing institutions based on the national registry, aiming to facilitate related research.


Time Coverage

As of July 31, 2023


Field Descriptions


Sample Data

This page displays partial tables due to the extensive dataset. For complete data, please view detailed sub-tables in the left navigation.

Basic Industrial and Commercial Data of Nucleic Acid Testing Institutions

Registered Capital Contribution Data of Nucleic Acid Testing Institutions

Shareholder Basic Data of Nucleic Acid Testing Institutions

Shareholders' External Investment Data of Nucleic Acid Testing Institutions

External Investment Data of Nucleic Acid Testing Institutions


Data Update Frequency

Annual updates